Temozolomide is an effective alkylating agent that is increasingly used for the treatment of pediatric brain tumors. Secondary, or treatment-related, myelodysplasia is a life-threatening complication of alkylating chemotherapy and has been reported in children with brain tumors after treatments other than temozolomide. We describe for the first time a case of temozolomide-related myelodysplasia in a child.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MPH.0b013e318182e74f | DOI Listing |
Publication Analysis
Top Keywords
brain tumors
8
treatment-related myelodysplastic
4
myelodysplastic syndrome
4
syndrome temozolomide
4
temozolomide child
4
child report
4
report temozolomide
4
temozolomide effective
4
effective alkylating
4
alkylating agent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!